8-K: Core Scientific to Merge with CoreWeave in All-Stock Deal

Core Scientific's Board unanimously recommends stockholders approve an all-stock merger with CoreWeave, citing a significant premium and de-risked growth path.

Summary

• Core Scientific, Inc. (Core Scientific) proposes an all-stock merger with CoreWeave, Inc. (CoreWeave).
• Core Scientific stockholders will receive 0.1235 newly-issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock held.
• The exchange ratio represents a ~71% premium to the 10-day VWAP exchange ratio as of June 25, 2025, prior to media reports.
• The exchange ratio increased by approximately 34% from CoreWeave's initial offer after extensive negotiations.
• Core Scientific stockholders are expected to hold an 8.9% ownership stake in the combined entity.
• The merger is expected to close in Q4 2025, subject to Core Scientific stockholder approval at a special meeting on October 30, 2025.
• The transaction aims to eliminate Core Scientific's standalone execution risk, including a projected ~$7.3 billion financing need for its data center buildout.
• The combined company anticipates over $500 million in fully ramped, annual run rate cost savings by the end of 2027, including lease overhead elimination.

Sentiment

Score: 9

Explanation: The filing presents a highly positive outlook for Core Scientific stockholders, offering a significant premium, de-risking the company's future, and providing exposure to a high-growth AI infrastructure leader. The elimination of substantial standalone financing needs and execution risks is a major positive.

Positives

• Core Scientific stockholders receive a ~71% premium to the unaffected 10-day VWAP exchange ratio.
• The exchange ratio increased by 34% from CoreWeave's initial offer, demonstrating strong negotiation by Core Scientific's Board.
• Eliminates Core Scientific's significant standalone execution risk, particularly the ~$7.3 billion capital expenditure requirement over eight years.
• Provides Core Scientific stockholders with ownership in a leading AI platform (CoreWeave) with strong momentum and high growth projections.
• The combined company is expected to achieve over $500 million in annual run rate cost savings by the end of 2027.
• Verticalization of operations creates a differentiated, large-cap AI infrastructure player with enhanced control over power footprint and design.
• Strengthens CoreWeave's capital position by converting a cash contract to an equity position and accelerates growth.
• CoreWeave's significant growth justifies potential multiple expansion, trading at a discount to publicly traded comparable companies despite higher growth projections.
• The transaction de-risks Core Scientific's ability to secure financing for data center buildout without customer contracts.

Negatives

• CoreWeave indicated unwillingness to pursue a fixed value deal or include cash in its proposal, limiting Core Scientific's options.
• Core Scientific's standalone plan faced significant capital expenditure needs (~$7.3 billion) and associated financing risks, which the merger addresses by eliminating the standalone plan.
• Core Scientific's standalone plan projected negative unlevered free cash flow (UFCF) for its Colocation Pipeline until 2030E.
• The standalone plan's pipeline CapEx buildout was significantly more expensive (approximately 8x higher per MW) than contracted CapEx, with much of it requiring pre-funding without customer contracts.

Risks

• Completion of the proposed transaction on anticipated terms or at all, including obtaining regulatory approvals and Core Scientific stockholder approval.
• Unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the combined company.
• The possibility that any anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• The ability of Core Scientific and CoreWeave to integrate their businesses successfully and to achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction.
• Disruptions from the proposed transaction harming Core Scientific's or CoreWeave's business, including current plans and operations, and diversion of management's time and attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and the combined company's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated.
• Development delays at data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.
• Core Scientific's ability to earn digital assets profitably and to attract customers for its high-density colocation capabilities (standalone risk, mitigated by merger).
• Price volatility of digital assets and bitcoin in particular (standalone risk, mitigated by merger's shift to AI infrastructure).
• Potential changes in the interpretive positions of the SEC or its staff with respect to digital asset mining firms (standalone risk, mitigated by merger's shift).

Future Outlook

The merger is expected to accelerate and de-risk the path to scale for both companies, creating a differentiated large-cap AI infrastructure player. The combined entity anticipates significant cost savings and greater financial flexibility, positioning it to capture a larger share of the rapidly growing AI infrastructure market, projected to reach ~$400 billion by 2028. CoreWeave's robust pipeline and recent large deals with OpenAI and Meta reinforce strong AI compute demand and its leadership position, suggesting potential for multiple expansion.

Management Comments

• The Core Scientific Board of Directors unanimously determined that the proposed transaction with CoreWeave represents the best available alternative for all Core Scientific stockholders and recommends all stockholders vote FOR the transaction.
• CoreWeave indicated it was unwilling to pursue a fixed value deal (with or without a collar) or include cash in its proposal, as such terms would not be acceptable to its Board.
• CoreWeave indicated that the June 27th offer represented its best and final offer and has since reaffirmed publicly on October 7th that its bid is best and final.
• We believe that our best-of-breed software and infrastructure solution makes us optimally suited to capture these bleeding-edge training workloads.
• We believe that the mix of hardware across generations will ensure that we are optimally situated to capture all workload types, both inference and training.

Industry Context

This merger signifies a strategic vertical integration within the rapidly expanding AI infrastructure market. Core Scientific, a data center operator, is transitioning from Bitcoin mining to high-performance computing (HPC) colocation, with CoreWeave already being its primary customer. The combination creates a vertically integrated entity, enhancing CoreWeave's control over its data center footprint and power capacity, crucial for scaling AI compute services. This move aligns with broader industry trends of cloud providers and AI companies seeking greater control over their physical infrastructure to optimize performance, cost, and delivery timelines for demanding AI workloads. CoreWeave's recent multi-billion dollar deals with OpenAI and Meta underscore the immense demand for specialized AI compute capacity, positioning the combined company to capitalize on this growth.

Comparison to Industry Standards

• CoreWeave currently trades at a significant discount to selected publicly traded pureplay and diversified cloud companies (e.g., Alphabet Inc., Amazon.com, Inc., Microsoft Corporation) based on consensus median TEV / EBITDA multiples, despite having meaningfully higher projected revenue growth (129.8% in 2026E) and EBITDA growth (154.2% in 2026E).
• The transaction's 71% premium to Core Scientific's 10-day VWAP unaffected exchange ratio places it within the top decile of all-stock exchange ratio transactions since 2004, indicating a historically outsized premium for Core Scientific stockholders.
• Core Scientific's standalone plan required CapEx per MW for its Colocation Pipeline to be approximately 8x higher than its contracted CapEx with CoreWeave, which is in line with typical data center builds, highlighting the cost efficiency gained through the existing CoreWeave funding arrangement and the merger.

Corporate Governance

Legal Proceedings

• Potential litigation relating to the proposed transaction that could be instituted against Core Scientific, CoreWeave or their respective directors and officers.

Related Party Transactions

• CoreWeave is Core Scientific's main colocation customer today and represents the vast majority of its total consolidated revenue in 2026E, making the merger a transaction between closely linked commercial partners.

Stakeholder Impact

• **Shareholders (Core Scientific):** Expected to benefit from a significant premium, de-risked future, and ownership in a high-growth AI infrastructure company. Voting 'FOR' the transaction is recommended by the Board.
• **Shareholders (CoreWeave):** Expected to benefit from vertical integration, cost savings, enhanced control over infrastructure, and accelerated growth in the AI market.
• **Employees:** The combined company anticipates significant cost savings through streamlining business operations, which could imply some workforce adjustments, though not explicitly stated.
• **Customers:** CoreWeave's customers (e.g., OpenAI, Meta) are expected to benefit from enhanced infrastructure control, optimized delivery timelines, and a strengthened end-to-end AI technology stack.
• **Creditors:** The combined company is expected to have greater financial flexibility and a lower overall cost of capital, potentially improving creditworthiness compared to Core Scientific's standalone plan.

Next Steps

• Core Scientific stockholders to consider and vote upon the proposal to adopt the Agreement and Plan of Merger at a Special Meeting scheduled for October 30, 2025.
• The proposed transaction is expected to close in Q4 2025.

Key Dates

Recommendation

For Core Scientific stockholders, the recommendation is a 'strong buy' on the merger proposal. The transaction offers a substantial 71% premium to the unaffected share price and eliminates the significant standalone execution risks, including a ~$7.3 billion capital expenditure requirement and negative free cash flow projections. By merging with CoreWeave, Core Scientific stockholders gain an 8.9% ownership stake in a rapidly growing, vertically integrated AI infrastructure leader with strong analyst sentiment and a clear path to capturing a larger share of the expanding AI market. The strategic benefits, cost synergies, and de-risking of Core Scientific's future make this a highly attractive proposition.

Keywords

Core Scientific, CoreWeave, Merger, Acquisition, All-stock transaction, AI infrastructure, Data center, Colocation, Bitcoin mining, SEC filing, CORZ, CORZW, CORZZ, High-performance computing, GPU cloud